The MSBA's Food Drug & Device Law Section Presents
Successful Strategies to Win
or to Defeat the Challenge
The Honorable Donovan W. Frank, U.S. District Judge, District of Minnesota
David P. Graham, Oppenheimer Wolff & Donnelly LLP
Michael K. Johnson, Johnson Becker
Gale D. Pearson (Moderator), Pearson Randall & Schumacher PA
At this "Lunch & Learn" seminar, attendees will learn:
- The Court's current view of the law of pre-emption in the context of FDA approved medical devices and pharmaceutical drugs.
- The Court will discuss its recent experiences and rulings as the MDL Judge in the Guidant litigation and its opinion in the Mensing decision, which eventually went to and was decided by, the U.S. Supreme Court.
- How pre-emption defenses differ when the case involves a manufacturer of a brand name drug, verses a manufacturer of a generic drug.
- Plaintiff’s strategies for defeating a pre-emption motion brought in a medical device case and a pharmaceutical drugs case.
- The status of pre-emption law in drug, device and food cases including how Bell Atlantic Corp. v. Twombly and Ashcroft v. Iqbal impacts pleadings to defeat pre-emption.
2 hours of Standard CLE credits have been applied for.
The event code is 163565.
Date: Monday, January 23, 2012
Time: 11:00 a.m. to 1:00 p.m.
Location: MSBA Offices,
600 Nicollet Mall #380, Mpls, MN 55402
Food Drug & Device Law Section Members: $15.00
MSBA Members: Join the Section and attend this meeting for FREE: $10.50
MSBA Member but n0t a Section Member: $20.00
Non-MSBA Members: $25.00
Law Students: Free
Teleconferencing is available. Teleconferencing instructions will be sent by e-mail on Friday, January 20.
Refunds will be processed for cancellation requests received in writing on or before noon on the registration deadline. Requests should be directed to the event contact person listed at the bottom of this notice. Cancellation requests received after this time are not eligible for refunds. You may send a colleague in your place if you are unable to join us and the registration deadline has passed.